As previously mentioned, EGFR expression is common in HNSCC and CAR-T cells targeting this receptor have demonstrated significant tumor control in EGFR positive HNSCC cell lines in early trials, as a result of enhanced cytokine production and improved target cell death after co-culture of CAR-T cells with target cells [25]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.